High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol

Magnetic Resonance in Medicine

Volumn 70, Issue 3, 2013, Pages 705-710

  Christen, Thomas ^a   Ni, Wendy ^a,b   Qiu, Deqiang ^a   Schmiedeskamp, Heiko ^a   Bammer, Roland ^a   Moseley, Michael ^a   Zaharchuk, Greg ^a  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

Author keywords

cerebral blood volume; dynamic susceptibility contrast; iron oxide; steady state

Indexed keywords

HEMODYNAMICS; IRON OXIDES; MAGNETIC SUSCEPTIBILITY; PETROLEUM RESERVOIR EVALUATION; SIGNAL TO NOISE RATIO;

CEREBRAL BLOOD VOLUME; DYNAMIC SUSCEPTIBILITY CONTRAST; DYNAMIC SUSCEPTIBILITY CONTRAST MRIS; HEALTHY VOLUNTEERS; LINEAR RELATIONSHIPS; QUANTITATIVE VALUES; STEADY STATE; VASCULAR STRUCTURES;

BLOOD;

FERUMOXYTOL; CONTRAST MEDIUM; MAGNETITE;

ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; FEMALE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE ANALYSIS; STEADY STATE; SUPERIOR SAGITTAL SINUS; BLOOD VOLUME; BRAIN CIRCULATION; DIAGNOSTIC USE; MIDDLE AGED; PROCEDURES;

ADULT; BLOOD VOLUME; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; FERROSOFERRIC OXIDE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84883234486     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24500     Document Type: Article

References (38)

1. Wu RH, Bruening R, Berchtenbreiter C, Weber J, Steiger HJ, Peller M, Penzkofer H, Reiser M,. MRI assessment of cerebral blood volume in patients with brain infarcts. Neuroradiology 1998; 40: 496-502.
2. Boxerman JL, Schmainda KM, Weisskoff RM,. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Am J Neuroradiol 2006; 27: 859-867.
3. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF,. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. Am J Neuroradiol 1998; 19: 1727-1732.
4. Mandeville JB, Marota JJA, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR, Weisskoff RM,. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 1998; 39: 615-624.
5. Mandeville JB, Marota JJ, Ayata C, Moskowitz MA, Weisskoff RM, Rosen BR,. MRI measurement of the temporal evolution of relative CMRO(2) during rat forepaw stimulation. Magn Reson Med 1999; 42: 944-951.
6. Barbier EL, Lamalle L, Décorps M,. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001; 13: 496-520.
7. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ,. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193: 637-641.
8. Paulson ES, Schmainda KM,. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008; 249: 601-613.
9. Troprès I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Décorps M,. Vessel size imaging. Magn Reson Med 2001; 45: 397-408.
10. Valable S, Lemasson B, Farion R, Beaumont M, Segebarth C, Remy C, Barbier EL,. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed 2008; 21: 1043-1056.
11. Lemasson B, Christen T, Tizon X, et al. Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects. NMR Biomed 2011; 24: 473-482.
12. Gahramanov S, Raslan AM, Muldoon LL, Hamilton BE, Rooney WD, Varallyay CG, Njus JM, Haluska M, Neuwelt EA,. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility- weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study. Int J Radiat Oncol Biol Phys 2011; 79: 514-523.
13. Dõsa E, Guillaume DJ, Haluska M, et al. Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol. Neuro oncol 2011; 13: 251-260.
14. Dõsa E, Tuladhar S, Muldoon LL, Hamilton BE, Rooney WD, Neuwelt EA,. MRI using ferumoxytol improves the visualization of central nervous system vascular malformations. Stroke 2011; 42: 1581-1588.
15. Otsu N,. A threshold selection method from graylevel histograms. IEEE Trans Syst Madn Cybern. 1979; 9: 62-66.
16. BjâŠ̃rnerud A, Johansson LO, Briley- SaebâŠ̃ K, Ahlström HK,. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange. Magn Reson Med 2002; 47: 461-471.
17. van Osch MJP, Vonken EPA, Viergever MA, van der Grond J, Bakker CJG,. Measuring the arterial input function with gradient echo sequences. Magn Reson Med 2003; 49: 1067-1076.
18. KjâŠ̃lby BF, Østergaard L, Kiselev VG,. Theoretical model of intravascular paramagnetic tracers effect on tissue relaxation. Magn Reson Med 2006; 56: 187-197.
19. Newbould RD, Skare ST, Jochimsen TH, Alley MT, Moseley ME, Albers GW, Bammer R,. Perfusion mapping with multiecho multishot parallel imaging EPI. Magn Reson Med 2007; 58: 70-81.
20. Straka M, Albers GW, Bammer R,. Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010; 32: 1024-1037.
21. Wu O, Østergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG,. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003; 50: 164-174.
22. Christen T, Schmiedeskamp H, Straka M, Bammer R, Zaharchuk G,. Measuring brain oxygenation in humans using a multiparametric quantitative blood oxygenation level dependent MRI approach. Magn Reson Med 2012; 68: 905-911.
23. Zaharchuk G, Straka M, Marks MP, Albers GW, Moseley ME, Bammer R,. Combined arterial spin label and dynamic susceptibility contrast measurement of cerebral blood flow. Magn Reson Med 2010; 63: 1548-1556.
24. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990; 113 (pt 1): 27-47.
25. Robinson SP, Howe FA, Griffiths JR, Ryan AJ, Waterton JC,. Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126. Int J Radiat Oncol Biol Phys 2007; 69: 872-879.
26. Pathak AP, Rand SD, Schmainda KM,. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose. J Magn Reson Imaging 2003; 18: 397-403.
27. Yablonskiy DA, Haacke EM,. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32: 749-763.
28. Klassen LM, Menon RS,. NMR simulation analysis of statistical effects on quantifying cerebrovascular parameters. Biophys J 2007; 92: 1014-1021.
29. Wu EX, Wong KK, Andrassy M, Tang H,. High-resolution in vivo CBV mapping with MRI in wild-type mice. Magn Reson Med 2003; 49: 765-770.
30. Hamilton BE, Nesbit GM, Dosa E, Gahramanov S, Rooney B, Nesbit EG, Raines J, Neuwelt EA,. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging. Am J Roentgenol 2011; 197: 981-988.
31. Calamante F,. Perfusion MRI using dynamic-susceptibility contrast MRI: quantification issues in patient studies. Top Magn Reson Imaging 2010; 21: 75-85.
32. Sakaie KE, Shin W, Curtin KR, McCarthy RM, Cashen TA, Carroll TJ,. Method for improving the accuracy of quantitative cerebral perfusion imaging. J Magn Reson Imaging 2005; 21: 512-519.
33. Kuppusamy K, Lin W, Cizek GR, Haacke EM,. In vivo regional cerebral blood volume: quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging. Radiology 1996; 201: 106-112.
34. Dunn JF, Roche MA, Springett R, Abajian M, Merlis J, Daghlian CP, Lu SY, Makki M,. Monitoring angiogenesis in brain using steady-state quantification of DeltaR2 with MION infusion. Magn Reson Med 2004; 51: 55-61.
35. Semmineh NB, Xu J, Quarles CC,. Characterizing the susceptibility calibration factor in heterogeneous vascular networks. In: Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 2012. Abstract 198.
36. Neuwelt EA, Várallyay CG, Manninger S, et al. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study. Neurosurgery 2007; 60: 601-611; discussion 611-612.
37. Mandeville JB,. IRON fMRI measurements of CBV and implications for BOLD signal. NeuroImage 2012; 62: 1000-1008.
38. Qiu D, Zaharchuk G, Christen T, Ni WW, Moseley ME,. Contrast-enhanced functional blood volume imaging (CE-fBVI): enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol. Neuroimage 2012; 62: 1726-1731.